Billions Co.,Ltd. Share Price

Equities

A044480

KR7044480002

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 27/06/2024 BST 5-day change 1st Jan Change
853 KRW +0.35% Intraday chart for Billions Co.,Ltd. -0.70% -24.51%

Financials

Sales 2022 78.06B 56.52M 4.48B Sales 2023 96.99B 70.22M 5.56B Capitalization 38.52B 27.89M 2.21B
Net income 2022 -18.45B -13.36M -1.06B Net income 2023 -13.81B -10M -792M EV / Sales 2022 0.58 x
Net cash position 2022 2.91B 2.11M 167M Net Debt 2023 28.72B 20.79M 1.65B EV / Sales 2023 0.69 x
P/E ratio 2022
-2.62 x
P/E ratio 2023
-2.72 x
Employees 91
Yield 2022 *
-
Yield 2023
-
Free-Float 70.27%
More Fundamentals * Assessed data
Dynamic Chart
Humasis Co. Ltd. completed the acquisition of 34.80% stake in BLADE Entertainment CO.,LTD. from Metaplex Co., Ltd. and Flake Co., Ltd. CI
Humasis Co. Ltd. entered into an agreement to acquire 34.80% stake in BLADE Entertainment CO.,LTD. from Metaplex Co., Ltd. and Flake Co., Ltd for KRW 48 billion. CI
BLADE Entertainment CO.,LTD. announced that it has received KRW 1.999999596 billion in funding CI
Blade Entertainment to Raise 2 Billion Won From Shares Issuance; Shares Climb 4% MT
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 1.999999596 billion in funding CI
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 10 billion in funding CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD. CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6 billion in funding CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6 billion in funding CI
Blueberry NFT CO.,LTD. announced that it has received KRW 5 billion in funding from Metaplex Co., Ltd. CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 5 billion in funding from Metaplex Co., Ltd. CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6.999999435 billion in funding from Jang San Co.,Ltd. CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6.999999435 billion in funding from Jang San Co.,Ltd. CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd. CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd. CI
More news
1 day+0.35%
1 week-0.70%
Current month-14.01%
1 month-25.18%
6 months-23.84%
Current year-24.51%
More quotes
1 week
824.00
Extreme 824
879.00
1 month
824.00
Extreme 824
1 073.00
Current year
824.00
Extreme 824
1 730.00
1 year
824.00
Extreme 824
1 730.00
3 years
824.00
Extreme 824
4 945.00
5 years
824.00
Extreme 824
9 430.00
10 years
824.00
Extreme 824
19 650.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 -
Chief Executive Officer 52 -
Comptroller/Controller/Auditor 52 -
Members of the board TitleAgeSince
Chief Executive Officer 52 -
Chief Executive Officer 46 -
Director/Board Member 65 -
More insiders
Date Price Change Volume
28/06/24 853 +0.35% 61,561
27/06/24 850 +0.95% 88,907
26/06/24 842 +0.24% 156,421
25/06/24 840 -0.47% 145,437
24/06/24 844 -0.59% 104,694

End-of-day quote Korea S.E., June 27, 2024

More quotes
Billions Co Ltd, formerly Blade Entertainment Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the manufacture and sale of medicines such as vitamins, placentas and health foods. The Company is also engaged in the manufacture and sale of rubber products such as condoms and gloves, as well as masks such as KF-94. In addition, the Company is engaged in the development and provision of software such as non-fungible tokens (NFTs).
More about the company
  1. Stock Market
  2. Equities
  3. A044480 Stock